The store will not work correctly when cookies are disabled.
Ethyl 2-(((4-methylpent-3-en-1-yl)(1-naphthyloxy)phosphoryl)amino)acetate
ID: ALA4780307
PubChem CID: 162662771
Max Phase: Preclinical
Molecular Formula: C20H26NO4P
Molecular Weight: 375.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)CNP(=O)(CCC=C(C)C)Oc1cccc2ccccc12
Standard InChI: InChI=1S/C20H26NO4P/c1-4-24-20(22)15-21-26(23,14-8-9-16(2)3)25-19-13-7-11-17-10-5-6-12-18(17)19/h5-7,9-13H,4,8,14-15H2,1-3H3,(H,21,23)
Standard InChI Key: BBXRNDBOBQPOMY-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
5.4438 -12.5385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8607 -13.2525 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
6.2691 -12.5360 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3071 -13.6653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0148 -13.2567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7267 -13.6653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0148 -12.4353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4385 -13.2567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1503 -13.6653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5740 -13.6653 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5712 -14.4866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8553 -14.8944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8522 -15.7150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5631 -16.1268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2784 -14.8971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2779 -15.7147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9851 -16.1201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6892 -15.7132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6858 -14.8925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9821 -14.4866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0904 -12.5336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5010 -11.8205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3223 -11.8180 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0861 -11.1099 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7330 -12.5286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5543 -12.5261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 5 1 0
5 6 2 0
5 7 1 0
6 8 1 0
8 9 1 0
9 2 1 0
2 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 16 1 0
15 11 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 15 2 0
3 21 1 0
21 22 1 0
22 23 1 0
22 24 2 0
23 25 1 0
25 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 375.41 | Molecular Weight (Monoisotopic): 375.1599 | AlogP: 4.92 | #Rotatable Bonds: 9 |
Polar Surface Area: 64.63 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.72 | CX Basic pKa: ┄ | CX LogP: 3.50 | CX LogD: 3.50 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.38 | Np Likeness Score: 0.16 |
References
1. Lentini NA,Schroeder CM,Harmon NM,Huang X,Schladetsch MA,Foust BJ,Poe MM,Hsiao CC,Wiemer AJ,Wiemer DF. (2021) Synthesis and Metabolism of BTN3A1 Ligands: Studies on Modifications of the Allylic Alcohol., 12 (1): [PMID:33488975] [10.1021/acsmedchemlett.0c00586] |